First Online: 5 June 2020
: N.E, T.G, M.K.K, G.M.C., J.M.T. and H.R. are shareholders in and/or employees of Helix Nanotechnologies Inc., which is developing gene-encoded vaccines for SARS-CoV-2. A full list of G.M.C.’s technology transfer, advisory roles and funding sources can be found at ExternalRef removed. J.M.T. is a shareholder and employee of SmartPharm Therapeutics, which is developing gene-encoded antibody vaccines for SARS-CoV-2.
Free to read: This content has been made available to all.